COMMUNIQUÉS West-GlobeNewswire

-
DBV Technologies participera à la 45e conférence annuelle Goldman Sachs Global Healthcare
05/06/2024 -
AVITA Medical Achieves Milestone with First Case Using RECELL GO
05/06/2024 -
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
05/06/2024 -
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
05/06/2024 -
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024 -
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
05/06/2024 -
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe
05/06/2024 -
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
05/06/2024 -
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
05/06/2024 -
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024 -
Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
05/06/2024 -
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/06/2024 -
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
05/06/2024 -
Oxford Treatment Center Launches New Christian-Based Treatment Program for Those Struggling with Drug and Alcohol Addiction
05/06/2024 -
Dr María José Torres, responsable du département d’allergologie à l’Hôpital universitaire régional de Malaga, nouvelle présidente de l’EAACI
05/06/2024 -
New Nymbl Science Report Asks: Are Falls an Invisible Epidemic?
05/06/2024 -
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024 -
Intercept Presents New Data on the Results of OCA-Bezafibrate Combination Therapy in PBC After Six Months of Treatment in Late-Breaking Poster Presentation at EASL Congress 2024
05/06/2024 -
InflaRx Hosts R&D Event Highlighting the Promise of INF904
05/06/2024
Pages